Valneva SE (VALN) Shares Outstanding (Diluted Average) (2021 - 2023)
Valneva SE's (VALN) quarterly Shares Outstanding (Diluted Average) came in at $139.53 in Q1 2023, down 48.2% year-on-year from $269.36 in Q1 2022, and down 84.96% quarter-over-quarter from $927.61 in Q3 2022.
Valneva SE (VALN) Shares Outstanding (Diluted Average) (2021 - 2023) Analysis & Trends
Valneva SE has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $139.53 for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 92.44 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 139.53 |
| Sep 30, 2022 | 927.61 |
| Mar 31, 2022 | 269.36 |
| Sep 30, 2021 | 2,960.01 |